rosiglitazone has been researched along with sparstolonin b in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, S; Duan, J; Fan, D; Lei, L; Li, J; Liang, Q; Liu, J; Zhang, J | 1 |
1 other study(ies) available for rosiglitazone and sparstolonin b
Article | Year |
---|---|
Protective effects of Sparstolonin B, a selective TLR2 and TLR4 antagonist, on mouse endotoxin shock.
Topics: Animals; Body Temperature; Cell Line; Chemokine CCL2; Disease Models, Animal; Drugs, Chinese Herbal; Female; Heterocyclic Compounds, 4 or More Rings; Inflammation; Interleukin-1beta; Interleukin-6; Lipopeptides; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; PPAR gamma; Rosiglitazone; Sepsis; Shock, Septic; Thiazolidinediones; Toll-Like Receptor 2; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2015 |